Thank you very much, Mr. Chair.
I want to thank all our witnesses for joining us today.
My first question is for Ms. Akugizibwe, and perhaps also for Dr. Plummer, who mentioned his work in Nairobi during his presentation. He could perhaps answer me.
During our discussion with the previous panel of witnesses, we tried, with the help of a Doctors Without Borders representative, to understand why Apotex took so long to deliver the medicines. The reason given was that it was difficult to come to an agreement with a recipient country. The representative said that potential recipients were not quite sure how to use Canada's Access to Medicines Regime.
Is that your experience as well? Is that what you see in the field?